Literature DB >> 26213187

Evaluation of Lewis blood group antigens and secretor status in pemphigus vulgaris.

M Shahidi-Dadras1, A Golfeshan1.   

Abstract

BACKGROUND: There has not been publication of any previous study about the role of secretory status or Lewis phenotypes in the mechanisms of pemphigus vulgaris (PV). AIM: To evaluate the frequencies of secretory status and Lewis phenotypes in patients with PV compared with healthy controls (HCs) in order determine their roles in this autoimmune disease.
METHODS: In total, 50 patients and 100 age- and sex-matched HCs were selected to form the study population, and 2 mL blood were collected from each subject to identify their Lewis phenotype. In subjects with the Le(a-b-) phenotype, saliva was also collected to determine secretor status.
RESULTS: The frequency of the nonsecretor (NS) phenotypes Le(a+b-) and Le(a-b-) together was significantly higher in patients than in HCs: 34/50 (68%)vs. 26/100 (26%), respectively (P < 0.001). All the patients and HC subjects with the Le (a-b-) phenotype were found to be NS by haemagglutination inhibition assay of saliva samples.
CONCLUSION: Based on our results, it seems that Le/b-negative NS individuals are more susceptible to PV.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26213187     DOI: 10.1111/ced.12707

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Secretor Status of ABO Antigens in Saliva of a Defined Group of Iranian Patients with Pemphigus Vulgaris: A Case-Control Study.

Authors:  Sedigheh Bakhtiari; Zahra Yadegari; Marziyeh Kaviyani; Zahra Namazi; Mahin Bakhshi
Journal:  Scientifica (Cairo)       Date:  2020-07-28

2.  Is There a Relation between ABO Blood Groups and Clinical Outcome in Patients with Pemphigoid? A Case-Control Study.

Authors:  Sedigheh Bakhtiari; Parviz Toosi; Somayyeh Azimi; Nafiseh Esmaili; Ali Montazami; Nasrin Rafieian
Journal:  Dermatol Res Pract       Date:  2016-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.